BioSpace News Archive

Press Releases

Lilly’s EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis

March 30, 2026
·
15 min read
Press Releases

Murad Alam, MD, MSCI, MBA, FAAD, assumes presidency of the American Academy of Dermatology

March 30, 2026
·
2 min read
Press Releases

Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

March 30, 2026
·
5 min read
Press Releases

UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis

March 30, 2026
·
17 min read
Press Releases

Dizal’s ZEGFROVY® (Sunvozertinib) Shows Profound Antitumor Activity as First-Line Treatment in Advanced NSCLC Patients with PACC or Other Uncommon Mutations at ELCC 2026

March 30, 2026
·
6 min read
Press Releases

Lebrikizumab delivered long-term disease control for up to four years in patients with moderate-to-severe atopic dermatitis

March 30, 2026
·
9 min read
Press Releases

Ascelia Pharma Announces Acceptance of Orviglance Data for Oral Presentation at the Annual Radiology Congress ESGAR 2026

March 30, 2026
·
2 min read
Press Releases

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138

March 30, 2026
·
6 min read
Press Releases

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

March 30, 2026
·
25 min read
Press Releases

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

March 30, 2026
·
10 min read